Compare MEI & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MEI | PYXS |
|---|---|---|
| Founded | 1946 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.3M | 243.5M |
| IPO Year | N/A | 2021 |
| Metric | MEI | PYXS |
|---|---|---|
| Price | $6.81 | $4.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 4 |
| Target Price | ★ $11.50 | $7.00 |
| AVG Volume (30 Days) | 313.4K | ★ 705.8K |
| Earning Date | 12-03-2025 | 11-03-2025 |
| Dividend Yield | ★ 2.93% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $984,400,000.00 | $2,820,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.41 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.08 | $0.83 |
| 52 Week High | $13.58 | $5.55 |
| Indicator | MEI | PYXS |
|---|---|---|
| Relative Strength Index (RSI) | 44.02 | 50.05 |
| Support Level | $6.51 | $4.11 |
| Resistance Level | $8.72 | $4.61 |
| Average True Range (ATR) | 0.46 | 0.42 |
| MACD | -0.04 | -0.13 |
| Stochastic Oscillator | 14.45 | 33.51 |
Methode Electronics Inc supplier of custom-engineered solutions with sales, engineering, and manufacturing locations in North America, Europe, the Middle East, and Asia. It designs, engineers, and produces mechatronic products for Original Equipment Manufacturers (OEMs) utilizing a broad range of technologies for user interface, light-emitting diode (LED) lighting systems, power distribution, and sensor applications. The firm is organized into various business segments: Automotive, Industrial, Interface, and Medical. The Automotive segment, which generates maximum revenue, supplies electronic and electro-mechanical devices and related products to automobiles, including overhead and center consoles, hidden and ergonomic switches, insert molded components, LED-based lighting, and sensors.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.